Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 79 citing Keilani: Improvement of lipid abnormalities associated with proteinuria using fosinopril,.... (0.09 sec) 

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized …

- diabetesjournals.org [PDF] 
P Tatti, M Pahor, RP Byington, P Di Mauro, R … - Diabetes Care, 1998 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS — The FACET was an open-label, randomized
prospective trial comparing fosinopril to amlodipine in hype rtensive people
with NIDDM. Patients we re men and women re c ruited from 1 J anua ry ...
Cited by 858 - Related articles - BL Direct - All 7 versions

The renin-angiotensin-aldosterone system: a specific target for hypertension management


MR Weir, VJ Dzau - American journal of hypertension, 1999 - nature.com
Angiotensin II plays a central role in the regulation of systemic arterial
pressure through its systemic synthesis via the renin-angiotensin-aldosterone
cascade. It acts directly on vascular smooth muscle as a potent ...
Cited by 203 - Related articles - All 7 versions

[BOOK] Lipids and the kidney


WF Keane, WH Hörl, BL Kasiske, 1997 - books.google.com
Lipids and the Kidney Volume Editors WF Keane. Minneapolis. Minn. WH Hfirl.
Vienna Bl. Kasiske. Minneapolis. Minn. 43 figures. 2 in color. and 20 tables.
1997 ix A r\ frr\ Basel• Freiburg• Paris• London• New York• V^ ...
Cited by 163 - Related articles - BL Direct - All 9 versions

Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, …

- annals.org [PDF] 
KJ Harjai - Annals of internal medicine, 1999 - Am Coll Physicians
The 1996 Bethesda Conference acknowledged left ventric- ular hypertrophy,
hyperhomocysteinemia, lipoprotein(a) excess, hypertriglyceridemia, oxidative
stress, and hyper- fibrinogenemia as possible new cardiac risk factors. ...
Cited by 131 - Related articles - BL Direct - All 7 versions

Thrombosis and hemostasis in renal disease


AJ Rabelink, JJ Zwaginga, HA Koomans, JJ … - Kidney international, 1994 - nature.com
Correspondence: AJ Rabelink MD, Dept. of Nephrology and Hypertension (F03.226),
University Hospital Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands.
... Received 25 October 1993; Revised 15 February 1994; Accepted 17 ...
Cited by 116 - Related articles - BL Direct - All 3 versions

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in …


JCN Chan, GTC Ko, DHY Leung, RCK Cheung, … - Kidney international, 2000 - ingentaconnect.com
In hypertensive type 2 diabetic patients, treatment with angiotensin-converting
enzyme (ACE) inhibitors is associated with a lower incidence of cardiovascular
events than those treated with calcium channel-blocking agents. However, ...
Cited by 116 - Related articles - BL Direct - All 7 versions

Lipid-lowering therapy in patients with renal disease


ZA Massy, JZ Ma, TA Louis, BL Kasiske - Kidney international, 1995 - nature.com
Lipid-lowering therapy in patients with renal disease. A growing number of
clinical trials have examined the effects of different lipid lowering strategies
in patients with renal disease. We carried out a meta-analysis to compare ...
Cited by 108 - Related articles - BL Direct - All 4 versions

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a …


B Kasiske, FG Cosio, J Beto, K Bolton, BM … - American Journal of Transplantation, 2004 - interscience.wiley.com
The incidence of cardiovascular disease (CVD) is very high in patients with
chronic kidney (CKD) disease and in kidney transplant recipients. Indeed,
available evidence for these patients suggests that the 10-year cumulative ...
Cited by 102 - Related articles - BL Direct - All 5 versions

Will angiotensin II receptor antagonists be renoprotective in humans?


I Ichikawa - Kidney international, 1996 - nature.com
Kidney International aims to inform the renal researcher and practicing nephrologists
on all aspects of renal research. Clinical and basic renal research, commentaries ...
Cited by 89 - Related articles - BL Direct - All 3 versions

Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis


GF Grauer, DS Greco, DM Getzy, LD Cowgill, … - Journal of Veterinary Internal Medicine, 2000 - apt.allenpress.com
A blinded, multicenter, prospective clinical trial assessed the effects of
enalapril (EN) versus standard care in dogs with naturally occurring, idiopathic
glomerulonephritis (GN). Twenty-nine adult dogs with membranous (n = 16) ...
Cited by 52 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google